Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,468 | -7,590 |
| Depreciation Amortization | 306 | 190 |
| Accounts receivable | -133 | N/A |
| Other Working Capital | 289 | -1,230 |
| Other Operating Activity | -97 | 800 |
| Operating Cash Flow | $-5,104 | $-7,830 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 1,500 | N/A |
| PPE Investments | -397 | -900 |
| Other Investing Activity | 0 | -6,000 |
| Investing Cash Flow | $1,103 | $-6,900 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,003 | N/A |
| Dividend Paid | N/A | -350 |
| Other Financing Activity | 0 | 14,630 |
| Financing Cash Flow | $1,003 | $14,280 |
| Exchange Rate Effect | 26 | 50 |
| Beginning Cash Position | 3,719 | 4,120 |
| End Cash Position | 747 | 3,710 |
| Net Cash Flow | $-2,973 | $-400 |
| Free Cash Flow | ||
| Operating Cash Flow | -5,104 | -7,830 |
| Capital Expenditure | -397 | N/A |
| Free Cash Flow | -5,501 | -7,830 |